Docking study on chlorogenic acid as a potential H5N1 influenza A virus neuraminidase inhibitor

Medicinal Chemistry Research

Volumn 20, Issue 5, 2011, Pages 554-557

  Luo, Hua Jun ^a   Wang, Jun Zhi ^a   Chen, Jian Feng ^a   Zou, Kun ^a  

^a Medical College of Three Gorges University   (China)

Author keywords

Chlorogenic acid; Docking; H5N1 neuraminidase

Indexed keywords

ANTIVIRUS AGENT; ARGININE; CARBOXYL GROUP; CHLOROGENIC ACID; OSELTAMIVIR; SIALIDASE INHIBITOR; THREONINE; VIRUS SIALIDASE;

ARTICLE; BINDING SITE; CONTROLLED STUDY; DRUG PROTEIN BINDING; DRUG STRUCTURE; HYDROGEN BOND; INFLUENZA VIRUS A H5N1; MOLECULAR DOCKING; NONHUMAN; SIMULATION;

EID: 80052035759     PISSN: 10542523     EISSN: 15548120     Source Type: Journal    
DOI: 10.1007/s00044-010-9336-z     Document Type: Article

References (23)

1. Almeida AA, Farah A, Silva DA, Nunan EA, Gloria MB (2006) Antibacterial activity of coffee extracts and selected coffee chemical compounds against enterobacteria. J Agric Food Chem 54:8738-8743 (Pubitemid 44797518)
2. Bandyopadhyay G, Biswas T, Roy KC, Mandal S, Mandal C, Pal BC (2004) Chlorogenic acid inhibits Bcr-Abl tyrosine kinase and triggers p38 mitogen-activated protein kinase dependent apoptosis in chronicmyelogenous leukemic cells. Blood 104:2514-2522 (Pubitemid 39331855)
3. DeLano WL (2004) The PyMOL molecular graphics system. DeLano Scientific, San Carlos, USA
4. do Santos MD, Almeida MC, Lopes NP, de Souza GE (2006) Evaluation of the antiinflammatory, analgesic and antipyretic activities of the natural polyphenol chlorogenic acid. Biol Pharm Bull 29:2236-2240 (Pubitemid 44690948)
5. Du QS, Wang SQ, Chou KC (2007) Analogue inhibitors by modifying oseltamivir based on the crystal neuraminidase structure for treating drug-resistant H5N1 virus. Biochem Biophys Res Commun 362:525-531
6. Dunn CJ, Goa KL (1999) Zanamivir: a review of its use in influenza. Drugs 58:761-784 (Pubitemid 29520519)
7. Feng R, Lu Y, Bowman LL, Qian Y, Castranova V, Ding M (2005) Inhibition of activator protein-1, NF-kappaB, and MAPKs and induction of phase 2 detoxifying enzyme activity by chlorogenic acid. J Biol Chem 280:27888-27895 (Pubitemid 41076906)
8. Huang MT, Smart RC, Wong CQ, Conney AH (1988) Inhibitory effect of curcumin, chlorogenic acid, caffeic acid, and ferulic acid on tumor promotion in mouse skin by 12-O-tetradecanoylphorbol- 13-acetate. Cancer Res 48:5941-5946 (Pubitemid 18266780)
9. Katarina N, Slavica F, Danica A (2008) QSAR study of imidazoline antihypertensive drugs. Bioorganic Med Chem 16:7134-7140
10. Kono Y, Kashine S, Yoneyama T, Sakamoto Y, Matsui Y, Shibata H (1998) Iron chelation by chlorogenic acid as a natural antioxidant.Biosci Biotechnol Biochem 62:22-27 (Pubitemid 128475017)
11. Le QM, Kiso M, Someya K, Sakai YT, Nguyen TH, Nguyen KH, Pham ND, Ngyen HH, Yamada S, Muramoto Y, Horimoto T, Takada A, Goto H, Suzuki T, Suzuki Y, Kawaoka Y (2005) Avian flu: isolation of drug-resistant H5N1 virus. Nature 437:1108 (Pubitemid 41509341)
12. Lew W, Chen X, Kim CU (2000) Discovery and development of GS 4104 (oseltamivir): an orally active influenza neuraminidase inhibitor. Curr Med Chem 7:663-672 (Pubitemid 30396423)
13. McKimm-Breschkin JL (2000) Resistance of influenza viruses to neuraminidase inhibitors-a review. Antiviral Res 47:1-17 (Pubitemid 30621392)
14. Mishin VP, Hayden FG, Gubareva LV (2005) Susceptibilities of antiviral-resistant influenza viruses to novel neuraminidase inhibitors. Antimicrob Agents Chemother 49:4515-4520 (Pubitemid 41552580)
15. Nardini M, Cirillo E, Natella F, Scaccini C (2002) Absorption of phenolic acids in humans after coffee consumption. J Agric Food Chem 50:5735-5741
16. Petar MM (2009) On the structure-based design of novel inhibitors of H5N1 influenza A virus neuraminidase (NA). Biophys Chem 140:35-38
17. Russell RJ, Haire LF, Stevens DJ, Collins PJ, Lin YP, Blackburn GM, Hay AJ, Gamblin SJ, Skehel JJ (2006) The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design. Nature 443:45-49 (Pubitemid 44344043)
18. Shan JH, Fu J, Zhao ZH, Kong XQ, Huang H, Luo L, Yin ZM (2009) Chlorogenic acid inhibits lipopolysaccharide-induced cyclooxygenase- 2 expression in RAW264.7 cells through suppressing NF-jB and JNK/AP-1 activation. Int Immunopharmacol 1-7
19. Thompson MA (2004) ArgusLab 4.0.1. Planaria Software, LLC, Seattle, WA.
20. Thompson MA (2004b) Poster presentation: molecular docking using arguslab: an efficient shape-based search algorithm and the AScore scoring function. Fall ACS meeting, Philadelphia
21. Ward P, Small I, Smith J, Suter P, Dutkowski R (2005) Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic. J Antimicrob Chemother 55(Suppl. 1):i5-i21 (Pubitemid 40331165)
22. Zang LY, Cosma G, Gardner H, Castranova V, Vallyathan V (2003) Effect of chlorogenic acid on hydroxyl radical. Mol Cell Biochem 247:205-210 (Pubitemid 36798526)
23. Zhao Z, Shin HS, Satsu H, Totsuka M, Shimizu M (2008) 5-Caffeoylquinic acid and caffeic acid down-regulate the oxidative stress- and TNF-a-induced secretion of interleukin-8 from Caco-2 cells. J Agric Food Chem 56:3863-3868 (Pubitemid 351860195)